Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 164.15
-0.85 (-0.52%)
Apr 17, 2026, 10:30 AM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 139.68 million as of April 17, 2026. Its market cap has increased by 40.04% in one year.
Market Cap
139.68M
Enterprise Value
130.43M
Revenue
34.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
164.15
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 139.68M, an increase of 110.20%. That is a compound annual growth rate of 11.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 139.68M | 28.51% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 232.46B |
| GSK plc | 86.72B |
| Haleon | 32.14B |
| Smith & Nephew | 10.61B |
| Tristel | 183.34M |
| Animalcare Group | 169.85M |
| Optima Health | 160.24M |
| Scancell Holdings | 132.32M |